| Autor: |
McMillan, Campbell W., Shapiro, Sandor S., Whitehurst, Deborah, Hoyer, Leon W., Rao, A. ViJaya, Lazerson, Jack, Study Group, the Hemophilia |
| Zdroj: |
Blood; February 1988, Vol. 71 Issue: 2 p344-348, 5p |
| Abstrakt: |
During a 4-year multicenter cooperative study of acquired factor VIII inhibitors in persons with hemophilia A, new inhibitors were detected in 31 of 1,306 patients who entered the study without an inhibitor or the history of an inhibitor. The incidence of new inhibitors was eight per 1,000 patient-years of observation. The factor VIII:C level before inhibitor development was ≤0.03 U/mL in 29 individuals and 0.06 U/mL and 0.07 U/mL in the remaining two. Factor VIII:Ag levels were measured in 27 individuals and were < 0.03 U/mL in 23 and 0.05 to 0.11 U/mL in the remaining four. Maximum inhibitor levels ranged from 1.0 to 9,044 Bethesda U/mL. In seven patients under the age of 20, relatively weak inhibitors (none higher than 4.3 Bethesda U/mL) were detected on only a single occasion despite continued factor VIII challenge. In the other 24 patients with inhibitors detected on multiple occasions, 50% had appeared by age 20 and 71 % by age 30. Seventeen of the 31 inhibitors, including 12 of 15 with maximum values >10 Bethesda U/mL, developed within 75 exposure days to factor VIII.1988 byGrune & Stratton, Inc.0006-4971/88/7102-0005$3.00/0 |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
